Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressive therapy in bone marrow transplantation.

A J Barrett1

  • 1Department of Haematology, Royal Postgraduate Medical School, University of London, Hammersmith Hospital, U.K.

Immunology Letters
|July 1, 1991
PubMed
Summary

Immunosuppressive and immunomodulatory drugs are crucial for bone marrow transplantation (BMT). These therapies help prevent graft rejection, graft versus host disease (GvHD), and treat existing GvHD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Elastase-Like Enzyme of Platelets.

Thrombosis and haemostasis·2019
Same author

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.

Bone marrow transplantation·2017
Same author

High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.

Bone marrow transplantation·2017
Same author

Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.

Bone marrow transplantation·2016
Same author

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system.

Bone marrow transplantation·2016
Same author

Rapid Remission Induction and Improved Disease Free Survival in Acute Myeloid Leukaemia Using Daunorubicin, ARA-C, and CCNU.

Leukemia & lymphoma·2016

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Pharmacology

Background:

  • Bone marrow transplantation (BMT) relies heavily on immunosuppressive and immunomodulatory strategies.
  • Effective management of recipient immunity is critical for successful BMT outcomes.

Purpose of the Study:

  • To outline the central role of immunosuppressive and immunomodulatory techniques in BMT.
  • To detail the therapeutic aims of these agents in the context of transplantation.

Main Methods:

  • Utilizing a range of agents including steroids, cyclosporin, cytotoxic agents, irradiation, and monoclonal antibodies.
  • Employing diverse mechanisms of action to modulate the immune system.

Main Results:

  • Achieved suppression of recipient immunity to facilitate donor marrow engraftment.
  • Prevented graft rejection and graft versus host disease (GvHD).
  • Successfully treated established acute and chronic GvHD.

Conclusions:

  • Immunosuppressive and immunomodulatory therapies are indispensable in BMT.
  • These agents are vital for engraftment, preventing GvHD, and managing GvHD complications.

Related Experiment Videos